Cyst fluid biomarkers for intraductal papillary mucinous neoplasms of the pancreas: a critical review from the international expert meeting on pancreatic branch-duct-intraductal papillary mucinous neoplasms.

Published on Feb 1, 2015in Journal of The American College of Surgeons4.59
· DOI :10.1016/J.JAMCOLLSURG.2014.11.001
Ajay V. Maker24
Estimated H-index: 24
(UIC: University of Illinois at Chicago),
Silvia Carrara12
Estimated H-index: 12
+ 6 AuthorsWilliam R. Brugge82
Estimated H-index: 82
(Harvard University)
The recognition of pancreatic cysts and intraductal papillary mucinous neoplasms of the pancreas (IPMN) has increased largely secondary to greater utilization of high-quality cross-sectional abdominal imaging.1, 2 Although the general characteristics of IPMNs, radiographic diagnosis, cyst fluid composition, and their delineation from other pancreatic tumors have been well established, several issues regarding their growth and progression into malignancy remain poorly described. The degree of neoplastic transformation within IPMN is highly variable, from those with an entirely innocuous cell population typically resembling gastric epithelium and lacking any cytologic atypia, to those that have progressively increasing degrees of cytoarchitectural atypia. Though some patients with highly dysplastic and invasive IPMN may present with clinical symptoms or characteristic radiographic findings, including jaundice, an associated pancreatic mass, or main pancreatic duct dilation; increasingly IPMN are incidentally discovered. Once IPMN are radiographically diagnosed, there is currently no reliable way to determine the level of epithelial dysplasia or to predict the time frame of progression to high-grade dysplasia or cancer.3–6 A biologic marker of IPMNs is urgently needed – one that can be easily obtained and tested without significant morbidity for the patient. An evidence-based expert meeting on pancreatic branch-duct IPMNs (BD-IMPN) was held in Verona, Italy and the authors reviewed the current role of existing technologies and molecular markers for predicting the biological behavior of IPMNs. The status of endoscopic ultrasound (EUS) and EUS-guided fine needle aspiration (FNA) cytology, cyst fluid biochemistry, mucins, cytokines, DNA, and microRNA profiles were critically reviewed by the group in order to identify the most promising clinically relevant biomarkers, and to target analyses for further development. Endoscopic ultrasound Endoscopic ultrasound (EUS) is a highly sensitive imaging modality for the evaluation of pancreatic cystic lesions that was developed as a diagnostic modality, but rapidly gained a role in IPMN for morphologic assessment and for its interventional capabilities, namely aspiration of cyst fluid and fine-needle aspiration (FNA). Diagnosis of IPMN based solely on EUS findings requires attention to cyst size, characteristics of the cyst wall, internal characteristics of the cyst, communication with the MPD, and the existence of any background lesions. Using EUS morphologic parameters, the sensitivity, specificity and accuracy to differentiate between benign and malignant, or potentially malignant, cystic lesions has been reported to be between 56%–91%, 45%–60% and 51%–72%, respectively7, 8 Although evaluation and the differential diagnosis of cystic lesions based solely on EUS morphology is feasible; inter-observer variability, operator dependency, and moderate diagnostic performance limit its accuracy without the addition of cyst fluid aspiration and FNA cytology, especially for determination of high-risk IPMN without overt malignant features.
📖 Papers frequently viewed together
14 Authors (Masao Tanaka, ..., Kenji Yamao)
1,578 Citations
200 Citations
9 Authors (Masao Tanaka, ..., Seiki Matsuno)
1,913 Citations
#1Eliana Amato (University of Verona)H-Index: 13
#2Marco Dal Molin (University of Verona)H-Index: 24
Last. Aldo Scarpa (University of Verona)H-Index: 99
view all 19 authors...
Intraductal neoplasms are important precursors to invasive pancreatic cancer and provide an opportunity to detect and treat pancreatic neoplasia before an invasive carcinoma develops. The diagnostic evaluation of these lesions is challenging, as diagnostic imaging and cytological sampling do not provide accurate information on lesion classification, the grade of dysplasia or the presence of invasion. Moreover, the molecular driver gene mutations of these precursor lesions have yet to be fully ch...
207 CitationsSource
#1Michele T. Yip-Schneider (IU: Indiana University)H-Index: 26
#2Huangbing Wu (IU: Indiana University)H-Index: 11
Last. C. Max SchmidtH-Index: 20
view all 7 authors...
Background Mucinous pancreatic cysts (intraductal papillary mucinous neoplasm and mucinous cystic neoplasm) have the potential to progress to invasive pancreatic adenocarcinoma, presenting an opportunity for early detection, prevention, and cure. Serous cystic neoplasms (SCN) have no malignant potential, but can mimic mucinous pancreatic cysts on imaging. Therefore, identification of biomarkers that can distinguish between cystic lesions is critically important. We hypothesize that vascular endo...
50 CitationsSource
#1Teppei Aso (Kyushu University)H-Index: 14
#2Takao Ohtsuka (Kyushu University)H-Index: 37
Last. Masao Tanaka (Kyushu University)H-Index: 105
view all 14 authors...
OBJECTIVES: Aberrant expression of several microRNAs (miRs) has been reported in various neoplasms including intraductal papillary mucinous neoplasms (IPMNs) of the pancreas. MicroRNA-196a (miR-196a) is up-regulated in Barrett esophagus (characterized by intestinal metaplasia) and in colorectal cancer; this relationship between intestinal characteristics and miR-196a might also be applicable to intestinal-type IPMNs. The aim of this study was to evaluate whether intestinal-type IPMNs can be disc...
8 CitationsSource
#1Linda S. Lee (Brigham and Women's Hospital)H-Index: 21
Last. Darwin L. Conwell (Brigham and Women's Hospital)H-Index: 53
view all 10 authors...
OBJECTIVES: Current diagnostic tools for pancreatic cysts fail to reliably differentiate mucinous from nonmucinous cysts. Reliable biomarkers are needed. MicroRNAs (miRNA) may offer insights into pancreatic cysts. Our aims were to (1) identify miRNAs that distinguish benign from both premalignant cysts and malignant pancreatic lesions using formalin-fixed, paraffinembedded (FFPE) pathology specimens; (2) identify miRNAs that distinguish mucinous cystic neoplasm (MCN) from branch duct-intraductal...
23 CitationsSource
#1Mohammad A. Al-Haddad (IU: Indiana University)H-Index: 35
#2John M. DeWitt (IU: Indiana University)H-Index: 65
Last. Thomas F. Imperiale (IU: Indiana University)H-Index: 57
view all 13 authors...
Background Diagnosis of mucinous pancreatic cysts (MPCs) is challenging due to the poor sensitivity of cytology provided by EUS-guided-FNA (EUS-FNA). Objective To quantify the test characteristics of molecular (DNA) analysis in suspected low-risk MPCs. Design A prospective cohort study performed in between 2008 and 2011. Setting Academic referral center. Patients Consecutive patients who underwent EUS-FNA of suspected MPCs. Intervention EUS-FNA and molecular (DNA) analysis of cyst fluid. Main Ou...
77 CitationsSource
#1Hang He (Fudan University)H-Index: 9
#2Yang Di (Fudan University)H-Index: 17
Last. Deliang Fu (Fudan University)H-Index: 23
view all 10 authors...
: Pancreatic cancer is known for its poor prognosis and early lymphatic metastasis is a notable characteristic. microRNAs (miRNAs) have been shown to be involved in the initiation and progression of pancreatic cancer. We, therefore, established a screening strategy to find miRNAs related to the lymphatic metastasis of pancreatic cancer and explored the target genes of miRNAs. miRNA array profiles were analyzed in tissue samples [pancreatic ductal adenocarcinoma (PDAC) and matched adjacent benign...
28 CitationsSource
#1Kirsten M. W. Woolf (UR: University of Rochester)H-Index: 1
#2Hua Liang (UR: University of Rochester)H-Index: 34
Last. Zhongren Zhou (UR: University of Rochester)H-Index: 9
view all 6 authors...
BACKGROUND The diagnosis of pancreatic tumors is often complicated because of sampling and interpretive challenges. The current study was performed to determine the rates, types, and causes of diagnostic discrepancies. METHODS The authors retrospectively reviewed cytology cases from 2004 to 2010 using matched surgical resection cases as the gold standard. RESULTS A total of 733 cases were divided into 3 categories: 1) positive or suspicious (290 cases); 2) negative or atypical (403 cases); and 3...
43 CitationsSource
#1Marco Dal Molin (University of Verona)H-Index: 24
#2Hanno Matthaei (University of Bonn)H-Index: 19
Last. Anirban Maitra (JHUSOM: Johns Hopkins University School of Medicine)H-Index: 136
view all 16 authors...
Background Intraductal papillary mucinous neoplasms (IPMNs) are the most common cystic precursor lesions of invasive pancreatic cancer. The recent identification of activating GNAS mutations at codon 201 in IPMNs is a promising target for early detection and therapy. The purpose of this study was to explore clinicopathological correlates of GNAS mutational status in resected IPMNs.
122 CitationsSource
#1Ang Li (Johns Hopkins University)H-Index: 14
#2Jun Yu (Johns Hopkins University)H-Index: 154
Last. Michael Goggins (Johns Hopkins University)H-Index: 118
view all 7 authors...
Purpose: Our goal was to identify circulating micro RNA (miRNA) levels that could distinguish patients with low-stage pancreatic cancer from healthy and disease controls. Experimental Design: We measured 735 miRNAs in pancreatic cancer case and control sera by QRTPCR using TaqMan MicroRNA Arrays. After array analysis, we selected 18 miRNA candidates for validation in an independent set of cases and control samples. Results: Of the significantly elevated circulating miRNAs in patients with pancre...
195 CitationsSource
#1Mitsuro Kanda (Johns Hopkins University)H-Index: 46
#2Spencer Knight (Johns Hopkins University)H-Index: 7
Last. Michael Goggins (Johns Hopkins University)H-Index: 118
view all 16 authors...
Objective Pancreatic cysts are commonly detected in patients undergoing pancreatic imaging. Better approaches are needed to characterise these lesions. In this study we evaluated the utility of detecting mutant DNA in secretin-stimulated pancreatic juice. Design Secretin-stimulated pancreatic juice was collected from the duodenum of 291 subjects enrolled in Cancer of the Pancreas Screening trials at five US academic medical centres. The study population included subjects with a familial predispo...
133 CitationsSource
Cited By42
#1Aatur D. Singhi (University of Pittsburgh)H-Index: 41
#2Laura D. Wood (JHUSOM: Johns Hopkins University School of Medicine)H-Index: 57
Due to its poor prognosis and the late stage at which it is typically diagnosed, early detection of pancreatic cancer is a pressing clinical problem. Advances in genomic analysis of human pancreatic tissue and other biospecimens such as pancreatic cyst fluid, pancreatic juice and blood have opened the possibility of DNA-based molecular approaches for early detection of pancreatic cancer. In this Review, we discuss and focus on the pathological and molecular features of precancerous lesions of th...
1 CitationsSource
#1Laura Kane (Trinity College, Dublin)
view all 5 authors...
Pancreatic cancer (PC) is among the most aggressive types of cancer, having caused over 495,000 deaths worldwide in 2020, with increasing annual incidence. Pancreatic cystic lesions (PCLs) are protrusions found within or on the surface of the pancreas, and in many cases have the potential to become malignant. Current methods of characterising PCLs are imperfect and there is a profound need for improved diagnostic algorithms. This review highlights the importance of biological markers in the cont...
#1Luca Barresi (ISMETT)H-Index: 22
#2Michele Amata (ISMETT)H-Index: 5
Last. Ilaria Tarantino (ISMETT)H-Index: 20
view all 4 authors...
Pancreatic cystic lesions are increasingly found due to the extended use of radiographic imaging techniques. These lesions have a highly variable biological behavior, ranging from completely benign and non-evolutionary to invasive with metastatic potential. There is currently no single examination allowing to obtain a precise diagnosis in all cases. Instead, all available data is considered, piecing together a puzzle and coming as close as possible to the correct final diagnosis. Cystic fluid an...
#1Tatsuo Hata (Tohoku University)H-Index: 12
#2Masamichi Mizuma (Tohoku University)H-Index: 11
Last. Michiaki Unno (Tohoku University)H-Index: 67
view all 11 authors...
Pancreatic cystic neoplasms (PCNs) are a heterogeneous group with varying risks of malignancy. To explore the clinical utility of liquid biopsy in cyst type classification, we analyzed the GNAS/KRAS mutations in circulating cell-free DNA (cfDNA) obtained from 57 patients with histologically diagnosed PCNs, including 34 with intraductal papillary mucinous neoplasms (IPMNs) and compared the mutant allele prevalence and variant patterns with the paired resected specimens using next-generation seque...
#1Andrew Eiterman (The Ohio State University Wexner Medical Center)H-Index: 1
#2Ali Lahooti (The Ohio State University Wexner Medical Center)H-Index: 1
Last. Somashekar G. Krishna (The Ohio State University Wexner Medical Center)H-Index: 21
view all 3 authors...
Pancreatic cancer has a high mortality rate with minimal proven interventions. Intraductal Papillary Mucinous Neoplasms (IPMNs) are known precursor lesions for pancreatic cancer. Identification of pancreatic cysts has improved from advances in abdominal imaging. Despite multiple revisions of the international consensus recommendations and various guidelines by other major societies, successful risk stratification of the malignant potential of mucinous pancreatic cysts remains challenging. Specif...
1 CitationsSource
#1Marcia I. Canto (Johns Hopkins University)H-Index: 73
#2Tossapol Kerdsirichairat (Johns Hopkins University)H-Index: 7
Last. Christopher L. Wolfgang (Johns Hopkins University)H-Index: 102
view all 21 authors...
Background Screening high-risk individuals (HRI) can detect potentially curable pancreatic ductal adenocarcinoma (PDAC) and its precursors. We describe the outcomes of high-risk individuals (HRI) after pancreatic resection of screen-detected neoplasms.
9 CitationsSource
#2Mazhar Soufi (Indiana University Health)H-Index: 2
Last. C. Max SchmidtH-Index: 30
view all 7 authors...
Abstract Background Intraductal papillary mucinous neoplasms (IPMN) are precursors of pancreatic cancer. Potential biomarkers of IPMN progression have not been identified in urine. A few urinary biomarkers were reported to be predictive of pancreatic ductal adenocarcinoma (PDAC). Here, we seek to assess their ability to detect high-risk IPMN. Methods Urine was collected from patients undergoing pancreatic resection and healthy controls. TIMP-1(Tissue Inhibitor of Metalloproteinase-1), LYVE-1(Lym...
4 CitationsSource
#1Andrea Caravati (University of Verona)H-Index: 3
#2Stefano Andrianello (University of Verona)H-Index: 16
Last. Giovanni Marchegiani (University of Verona)H-Index: 29
view all 8 authors...
Background and Aims:Pancreatic cysts are increasingly diagnosed, mainly during abdominal imaging performed for other reasons. Between pancreatic cystic neoplasm, intraductal papillary mucinous neop...
#1Stephen Hasak (WashU: Washington University in St. Louis)H-Index: 7
#2Koushik K. Das (WashU: Washington University in St. Louis)H-Index: 11
Purpose: With the increased utilization of cross-sectional imaging, pancreatic cystic lesions (PCL) are common incidental findings, detected in up to 20% of abdominal MRI scans in adults. While PCL, especially mucinous PCL, have the capacity to develop into invasive carcinoma, it is increasingly being recognized that their malignant potential is neither uniform nor certain. Indeed, while data from long-term cohorts of PCL have identified a small but ongoing risk to the development of carcinoma, ...
#1Jan Rune Aunan (Stavanger University Hospital)H-Index: 3
#2Nigel B. Jamieson (Glas.: University of Glasgow)H-Index: 44
Last. Kjetil Søreide (Stavanger University Hospital)H-Index: 63
view all 3 authors...
Observation or resection of pancreatic intraductal papillary mucinous neoplasm: An ongoing tug of war
5 CitationsSource